{"id":"W2525038995","doi":"10.1158/1078-0432.ccr-16-0987","title":"A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Discontinuation; Dutasteride; Abiraterone acetate; Urology; Prednisone; Internal medicine; Clinical endpoint; Oncology; Enzalutamide; Cancer; Androgen receptor; Androgen deprivation therapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009247578,0.001331066,0.001546955,0.0003458083,0.0003688855,0.0006944276,0.0006077645,0.0007658828,0.003568291],"category_scores_gemma":[0.0007253579,0.0004850009,0.0008370429,0.0003408082,0.0006796055,0.0004124889,0.0002739914,0.002112667,0.0006092942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005335317,"about_ca_system_score_gemma":0.001323018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009127846,"about_ca_topic_score_gemma":0.002232,"domain_scores_codex":[0.9996947,0.0001509101,0.00001774421,0.00004680945,0.00003723006,0.00005266302],"domain_scores_gemma":[0.999358,0.00009757553,0.0001186267,0.00004753525,0.00003437357,0.0003438592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.853947,0.04195542,0.004218031,0.0007817414,0.001126174,0.0002225971,0.0001888355,0.00127155,0.03772047,0.0001479916,0.00150595,0.0569141],"study_design_scores_gemma":[0.6214087,0.367815,0.006700779,0.00002633213,0.0002519526,0.0002007133,0.0000361147,0.0005551741,0.002013874,0.00007933003,0.0008959431,0.00001612263],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956062,0.001437976,0.0002574645,0.0001685896,0.0000997522,0.001330289,0.0003330593,0.00004682792,0.0007198678],"genre_scores_gemma":[0.9938869,0.001084538,0.0007346291,0.0003215666,0.0001627196,0.001367062,0.0007360825,0.00001139795,0.00169521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003568291,"threshold_uncertainty_score":0.01193714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2647442452935844,"score_gpt":0.5426248698811699,"score_spread":0.2778806245875855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}